Financial Times reports Johnson & Johnson (JNJ.N) is seeking to acquire ophthalmology biotech Ollin Biosciences for up to $3.4 billion.

2026-11-16

Financial Times reports Johnson & Johnson (JNJ.N) is seeking to acquire ophthalmology biotech Ollin Biosciences for up to $3.4 billion.

Other News
2026-11-16

Japan's preliminary Q3 real GDP annualized fell 0.1% (first negative in a year), versus economists' +0.2% forecast. Private consumption, the largest GDP component, slid 0.3%; the BOJ said typhoons, heavy rain and rising living costs kept consumers—es

2026-11-15

Iranian Parliament Speaker Qassem Ghalibaf: Iran will not continue in a state of "neither war nor peace." For us, whether the US wants to negotiate or wage war is irrelevant. The door to an agreement will be open as long as the US accepts our seven r